Treatment Category Profile

Treatment Name:	Fused Dendritic-Tumour Vaccine	Known as: Also Known As:	Fused Dendritic-Tumour Vaccine
Treatment Type:	Immunotherapy	Status:	Clinical Trial (other Cancer)
In this therapy, immune system blood cells called dendritic cells are fused with tumor cells from the same patient. When the hybrid is injected back into the body, the immune system recognizes the cells as foreign since they contain bits of the patient?s tumor, and attacks them.

   Articles related to this Treatment

1 Genzyme Molecular Oncology (GZMO) Begins Kidney Cancer Clinical Trial - First Time Vaccine Approach Tested In The U.S. biospace Nov 6, 2002 2 GZMO Presents Data On New Cancer Vaccine Approach At Gene Therapy Conference Biospace Jun 8, 2002 3 Doubts raised over cancer vaccine study BMJ News Roundup Jul 28, 2001 4 Study of dendritic cell 'vaccine' shows early promise in helping the immune system combat an extremely aggressive type of brain cancer EurekaAlert Jan 31, 2001 5 Northwest Biotherapeutics awards cancer target manufacturing contract to Protein Sciences www.pharmaceuticalonline.com Oct 18, 2000 6 Cancer breakthrough: one step closer to a cure? Ninemsn Oct 12, 2000 7 Trying dendritic/tumor-cell fusion Oncology Week in Review Oct 5, 2000 8 Genzyme Molecular Oncology Announces Initiation Of Kidney Cancer And Melanoma Cancer Vaccine Clinical Trials Intellihealth Medical Network Oct 3, 2000 9 Fused ovarian cancer and dendritic cells stimulate T-cell response against tumor Reuters Health Sep 4, 2000 10 Vaccine Approach Offers Hope For Kidney Cancer cancerpage.com May 1, 2000 11 Dendritic Tumor Cell Vaccine for Renal Cancer Medscape Apr 27, 2000 12 dendritic/cancer cell fusion technology cancereducation.com Mar 17, 2000 13 Progress On Possible Vaccine For Kidney Cancer cancerpage.com Mar 1, 2000 14 Vaccine Effective In Treating Kidney Cancer that has Spread cancerpage.com Feb 29, 2000 15 Vaccine-like drug fights kidney cancer USA Today Feb 28, 2000 16 Novel vaccine wipes out some kidney tumors MSNBC Feb 28, 2000